Failure to achieve clinical response · Patients with active Crohn's disease
Antibiotic probably leads to lower failure to achieve clinical response compared with placebo (moderate certainty).
1 finding from 1 review
Failure to maintain endoscopic remission · Patients with active Crohn's disease
The review found no eligible studies for this question.
1 finding from 1 review
no estimate extracted
Studies not reported
No studies found
Adverse events · Patients with active Crohn's disease
Antibiotic showed no clear difference in adverse events compared with placebo (high certainty).
1 finding from 1 review
Serious adverse events · Patients with active Crohn's disease
Antibiotic showed no clear difference in serious adverse events compared with placebo (low certainty).
1 finding from 1 review
Withdrawals due to adverse events · Patients with active Crohn's disease
Antibiotic showed no clear difference in withdrawal due to adverse events compared with placebo (low certainty).
1 finding from 1 review
Change in BCVA (lower logMAR indicate better vision) · People with toxoplasma retinochoroiditis
1 finding from 1 review
or more recurrences of retinochoroiditis · People with toxoplasma retinochoroiditis
Antibiotic probably leads to lower or more recurrences of retinochoroiditis compared with no treatment (moderate certainty).
1 finding from 1 review
Improvement in intraocular inflammation · People with toxoplasma retinochoroiditis
Antibiotic showed no clear difference in improvement in intraocular inflammation compared with no treatment (low certainty).
1 finding from 1 review
Size of lesion · People with toxoplasma retinochoroiditis
The review found no eligible studies for this question.
1 finding from 1 review
no estimate extracted
Studies not reported
No studies found
Adverse events · People with toxoplasma retinochoroiditis
Antibiotic showed no clear difference in adverse events compared with no treatment (low certainty).
1 finding from 1 review
Neonatal sepsis · Women with meconium‐stained amniotic fluid in labour, gestational age more than 24 weeks
Antibiotic showed no clear difference in neonatal sepsis compared with placebo (low certainty).
1 finding from 1 review
Chorioamnionitis · Women with meconium‐stained amniotic fluid in labour, gestational age more than 24 weeks
Antibiotic probably leads to lower chorioamnionitis compared with placebo (moderate certainty).
1 finding from 1 review
Postpartum endometritis · Women with meconium‐stained amniotic fluid in labour, gestational age more than 24 weeks
Antibiotic showed no clear difference in postpartum endometritis compared with placebo (low certainty).
1 finding from 1 review
Mortality and morbidity prior to discharge (Neonatal intensive care admissions) · Women with meconium‐stained amniotic fluid in labour, gestational age more than 24 weeks
Antibiotic showed no clear difference in mortality and morbidity prior to discharge (Neonatal intensive care… compared with placebo (low certainty).
1 finding from 1 review
Side effects · Women with meconium‐stained amniotic fluid in labour, gestational age more than 24 weeks
The review found no eligible studies for this question.
1 finding from 1 review
no estimate extracted
Studies not reported
No studies found
Duration of admission to neonatal intensive care unit · Women with meconium‐stained amniotic fluid in labour, gestational age more than 24 weeks
The review found no eligible studies for this question.
1 finding from 1 review
no estimate extracted
Studies not reported
No studies found
Prevention ‐ any AOM or CSOM during intervention · patients with the prevention of acute and chronic suppurative otitis media in children
Antibiotic probably leads to lower prevention ‐ any AOM or CSOM during intervention compared with control ‐ primary outcomes (moderate certainty).
1 finding from 1 review
Side effects ‐ any clinical side effects during intervention · patients with the prevention of acute and chronic suppurative otitis media in children
Antibiotic showed no clear difference in side effects ‐ any clinical side effects during intervention compared with control ‐ secondary outcomes (moderate certainty).
1 finding from 1 review
Recurrence of symptomatic UTI: cotrimoxazole (1) versus cefprozil (2) · children with primarily normal renal tracts who have experienced at least one UTI
Antibiotic 1 showed no clear difference in recurrence of symptomatic UTI: cotrimoxazole (1) versus cefprozil (2) compared with antibiotic 2 (moderate certainty).
2 findings from 1 review
Microbial resistance to prophylactic drugs: nitrofurantoin (1) versus cotrimoxazole (2) · children with primarily normal renal tracts who have experienced at least one UTI
Antibiotic 1 probably leads to lower microbial resistance to prophylactic drugs: nitrofurantoin (1)… compared with antibiotic 2 (moderate certainty).
1 finding from 1 review